Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam Effect on Fluid Responsiveness in Sepsis
NCT02050893Phase 2Completed
- Sponsor
- Southeast University
- Start
- May 2012
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of midazolam in septic shock, sponsored by Southeast University. Started May 2012; status: completed.
02
Drugs
midazolam
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT02050893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02050893.